A Study of RGH-188 (Cariprazine) in Depression in bipolarity
This study is completed in the United States. It is testing RGH-188 (Cariprazine) for depression in bipolarity.
Bipolarity, DepressionDrugFrom 18 Years to 65 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether cariprazine may be useful for adults experiencing bipolarity.
What would participation involve?
Participants may receive cariprazine, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United States.
Who is it mainly for?
This study appears to be mainly for adults with bipolarity.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
United States · 26 sites
Forest Investigative Site 005
Encino, California
Site status: Not listed — confirm with the team
Forest Investigative Site 017
Garden Grove, California
Site status: Not listed — confirm with the team
Forest Investigative Site 027
National City, California
Site status: Not listed — confirm with the team
Forest Investigative Site 013
Newport Beach, California
Site status: Not listed — confirm with the team
Forest Investigative Site 010
Oceanside, California
Site status: Not listed — confirm with the team
Forest Investigative Site 020
Bradenton, Florida
Site status: Not listed — confirm with the team
Forest Investigative Site 007
Jacksonville, Florida
Site status: Not listed — confirm with the team
Forest Investigative Site 019
Kissimmee, Florida
Site status: Not listed — confirm with the team
Forest Investigative Site 026
Orlando, Florida
Site status: Not listed — confirm with the team
Forest Investigative Site 012
West Palm Beach, Florida
Site status: Not listed — confirm with the team
Forest Investigative Site 024
Glen Burnie, Maryland
Site status: Not listed — confirm with the team
Forest Investigative Site 029
Creve Coeur, Missouri
Site status: Not listed — confirm with the team
Forest Investigative Site 002
Omaha, Nebraska
Site status: Not listed — confirm with the team
Forest Investigative Site 028
Cherry Hill, New Jersey
Site status: Not listed — confirm with the team
Forest Investigative Site 001
The Bronx, New York
Site status: Not listed — confirm with the team
Forest Investigative Site 018
Durham, North Carolina
Site status: Not listed — confirm with the team
Forest Investigative Site 004
Dayton, Ohio
Site status: Not listed — confirm with the team
Forest Investigative Site 022
Mason, Ohio
Site status: Not listed — confirm with the team
Forest Investigative Site 015
Portland, Oregon
Site status: Not listed — confirm with the team
Forest Investigative Site 006
Media, Pennsylvania
Site status: Not listed — confirm with the team
Forest Investigative Site 011
Philadelphia, Pennsylvania
Site status: Not listed — confirm with the team
Forest Investigative Site 014
Nashville, Tennessee
Site status: Not listed — confirm with the team
Forest Investigative Site 023
Irving, Texas
Site status: Not listed — confirm with the team
Forest Investigative Site 003
Woodstock, Vermont
Site status: Not listed — confirm with the team
Forest Investigative Site 009
Bellevue, Washington
Site status: Not listed — confirm with the team
Forest Investigative Site 016
Seattle, Washington
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with bipolarity. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving cariprazine, placebo. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.
Who might this study be for?
This study may concern people with bipolarity; age range: From 18 Years to 65 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Forest Laboratories, which appears to be a pharmaceutical company. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
